Eden Research (LON:EDEN) Shares Up 2.8% After Insider Buying Activity

Eden Research plc (LON:EDENGet Free Report)’s stock price rose 2.8% during trading on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). Approximately 12,234,783 shares traded hands during trading, an increase of 664% from the average daily volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).

Specifically, insider Alexander John Abrey bought 540,540 shares of Eden Research stock in a transaction dated Tuesday, January 28th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,919.32).

Eden Research Price Performance

The stock’s 50-day moving average price is GBX 3.89 and its 200-day moving average price is GBX 4.01. The company has a market capitalization of £20.80 million, a price-to-earnings ratio of -200.00 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Featured Stories

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.

Eden Research (LON:EDEN) Shares Up 2.8% After Insider Buying Activity

Shares of Eden Research plc (LON:EDENGet Free Report) shot up 2.8% during trading on Tuesday following insider buying activity. The company traded as high as GBX 4.18 ($0.05) and last traded at GBX 3.70 ($0.05). 12,234,783 shares traded hands during mid-day trading, an increase of 664% from the average session volume of 1,602,016 shares. The stock had previously closed at GBX 3.60 ($0.04).

Specifically, insider Alexander John Abrey acquired 540,540 shares of the stock in a transaction that occurred on Tuesday, January 28th. The stock was bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £21,621.60 ($26,919.32).

Eden Research Stock Down 3.7 %

The company has a market capitalization of £20.80 million, a PE ratio of -200.00 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.25. The firm has a 50-day moving average of GBX 3.89 and a two-hundred day moving average of GBX 4.01.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.

Read More

Receive News & Ratings for Eden Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eden Research and related companies with MarketBeat.com's FREE daily email newsletter.